top of page
Indian Entomologist

Shifting from 9 to 12: CRISPR/Cas12a as a Revolutionary Tool for Insect Biologists

by Ashok Karuppannasamy, Yogi Dhawane and Asokan Ramasamy

 

The field of insect genome editing is transforming, and the shift from Cas9 to Cas12a is at the heart of it. The demonstration of CRISPR/Cas9-mediated editing in Bactrocera dorsalis represents a leap forward in understanding insect genetics. Ashok et al. (2023) edited an eye colour gene in B. dorsalis which resulted in a white eye colour phenotype (Figure 1). These visible alterations confirmed the efficacy of the CRISPR/Cas9 RNP-mediated editing and underscored its potential for functional genomic studies in non-model insects. However, in our recent study (Yogi et al., 2024), we unveiled a ground breaking advancement by harnessing the potential of CRISPR/Cas12a in a globally important agricultural pest, Spodoptera frugiperda - a non-model organism. This work represents a paradigm shift in insect molecular biology, promising new horizons for functional genomics and sustainable pest management.

Figure 1. Impact of CRISPR/Cas9 on the eye pigment of Bactrocera dorsalis. Reddish brown eye colour is the common phenotype found in B. dorsalis adults (Upper left). Complete white eye phenotype was observed in mutant adults (Upper right). The below represents the three-dimensional protein structures, black represents the guide region, and silver coloured ribbon the whole protein.

Why Cas12a?

CRISPR/Cas9 has been the go-to genome editing tool for years. However, Cas12a brings several unique advantages. Unlike Cas9, which requires a GC-rich protospacer adjacent motif (PAM), Cas12a can target T-rich PAMs. This feature greatly expands the range of target sites, especially in genomes with limited GC content. Cas12a causes staggered cuts in DNA, which makes it ideal for precision edits and multiplexing-editing multiple genes simultaneously.

 

The First Cas12a Application in non-model organism Spodoptera frugiperda

Our study is the first to successfully apply Cas12a in Spodoptera frugiperda, an invasive pest that defies most current management strategies. We targeted the tryptophan 2,3-dioxygenase gene, a crucial gene linked to eye colour. By microinjecting Cas12a ribonucleoprotein complexes (RNPs) into pre-blastoderm (G0) eggs, we achieved precise edits with deletions and insertions. The mutants exhibited phenotypic Validations with varied eye-colour phenotypes, which we further validated through in silico protein modeling to understand the underlying changes at the molecular level (Figure 2). This proof-of-concept underscores Cas12a’s utility for functional genomics in non-model insects.

Figure 2. Impact of CRISPR/Cas12a on the eye pigment of Spodoptera frugiperda. Black eye colour is the common phenotype found in S. frugiperda adults (Above). A complete yellow eye phenotype was observed in mutant adults (Below). The last couplet represents the three-dimensional protein structures, blue represents the guide region, and green represents the whole protein. The orange colour represents the non-native amino acid sequence.

Paving the way for genetic biocontrol

One of the most promising applications of genome editing in pest management is the precision-guided Sterile Insect Technique (pgSIT). Previously demonstrated in Drosophila melanogaster, this method holds tremendous potential for pests like S. frugiperda. By validating Cas12a in this species, we’ve laid the groundwork for developing advanced genetic biocontrol tools, including:


  1. Multiplexed Gene Targeting: Editing multiple genes simultaneously to disrupt pest fitness.

  2. Refined Biocontrol Strategies: Adapting pgSIT to the reproductive and ecological traits of agricultural pests.

  3. Controllable Gene Drives: Designing gene drives to ensure population suppression in a controlled and reversible manner.

 

Looking Ahead

This research not only marks a breakthrough in applying Cas12a to non-model insects but also sets the stage for broader applications in pest management. Moving forward, we aim to:


Ø  Explore additional target genes to assess Cas12a's versatility.

Ø  Develop multiplexing approaches for complex gene networks.

Ø  Tailor biocontrol methods to align with ecological sustainability.

 

Conclusion

The leap from Cas9 to Cas12a is more than a technical upgrade. It is a revolution in how we approach insect genome editing. By unlocking new possibilities for precise, efficient, and sustainable pest management, we are taking a significant step toward addressing global agricultural challenges. The future is bright, and it’s time to embrace the power of “12” for a transformative impact in entomology.

 

For more details, please refer:


Ashok, K., Bhargava, C.N., Asokan, R.*, Pradeep, C., Kennedy, J.S., Rai, A. and Manamohan, M., 2023. First report on the utility of pupal case for early determination of CRISPR/Cas9 ribonucleoprotein mediated genomic edits in the oriental fruit fly, Bactrocera dorsalis (Hendel)(Tephritidae: Diptera). Archives of Insect Biochemistry and Physiology113(4), p.e22024.


Yogi, D., Ashok, K.*, Anu, C.N., Shashikala, T., Pradeep, C., Bhargava, C.N., Parvathy, M.S., Jithesh, M.N., Manamohan, M., Jha, G.K. and Asokan, R.* (2024). CRISPR/Cas12a ribonucleoprotein mediated editing of tryptophan 2, 3-dioxygenase of Spodoptera frugiperdaTransgenic Research, pp.1-13.

 

Ashok Karuppannasamy is one of the Associate Editors of Indian Entomologist. He works as a Post Doctoral Fellow, at Tata Institute for Genetics and Society, InStem Building, NCBS Campus, Bengaluru, Karnataka, India.


Yogi Dhawane is currently a Research Associate at ICAR – Indian Institute of Horticultural Research, Bengaluru and also pursuing his Doctoral degree program from Jain University, Bengaluru, Karnataka, India.

 

Asokan Ramasamy is presently working as a Principal Scientist, at ICAR – Indian Institute of Horticultural Research, Bengaluru, Karnataka, India.

 

Disclaimer: The contents, style, language, plagiarism, references, mention of any products if any, etc., are the sole responsibility of the authors.


531 views0 comments

Comments


bottom of page